US 11896672
Targeted nucleic acid conjugate compositions
granted A61KA61K31/713A61K47/549
Quick answer
US patent 11896672 (Targeted nucleic acid conjugate compositions) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/713, A61K47/549, A61K47/554, A61K47/59